Vical (VICL) Tops Q2 EPS by 3c

Vical (NASDAQ: VICL) reported Q2 EPS of ($0.03), $0.03 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.8 million.

For earnings history and earnings-related data on Vical (VICL) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Pulmatrix (PULM) Reports Q2 Loss of $0.29
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating